Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F23%3A10458588" target="_blank" >RIV/00064203:_____/23:10458588 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11130/23:10458588
Výsledek na webu
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=wMpEgMXIFf" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=wMpEgMXIFf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3324/haematol.2022.281788" target="_blank" >10.3324/haematol.2022.281788</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia
Popis výsledku v původním jazyce
Although initial central nervous system (CNS) involvement is rarely detected in childhood acute lymphoblastic leukemia (ALL), risk-adapted CNS-directed therapy is essential for all patients. Treatment intensity depends on the initial CNS status. In trial AIEOP-BFM ALL 2009, patients with cytomorphological detection of leukemic blasts in initial cerebrospinal fluid were classified as CNS2 or CNS3 and received five intrathecal doses of methotrexate in induction therapy compared to patients with CNS1 status (no blasts detected) who received three doses. The impact of additional intrathecal methotrexate on systemic toxicity in induction therapy is unknown. Between June 01, 2010 and February 28, 2017, 6136 patients at the age of 1 to 17 years with ALL were enrolled onto the trial AIEOP-BFM ALL 2009. The effect of three versus five doses of intrathecal methotrexate during induction therapy on the incidence of severe infectious complications was analyzed. Among 4706 patients treated with three intrathecal methotrexate doses, 77 (1.6%) had a lifethreatening infection during induction as compared to 59 of 1350 (4.4%) patients treated with five doses (p.
Název v anglickém jazyce
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia
Popis výsledku anglicky
Although initial central nervous system (CNS) involvement is rarely detected in childhood acute lymphoblastic leukemia (ALL), risk-adapted CNS-directed therapy is essential for all patients. Treatment intensity depends on the initial CNS status. In trial AIEOP-BFM ALL 2009, patients with cytomorphological detection of leukemic blasts in initial cerebrospinal fluid were classified as CNS2 or CNS3 and received five intrathecal doses of methotrexate in induction therapy compared to patients with CNS1 status (no blasts detected) who received three doses. The impact of additional intrathecal methotrexate on systemic toxicity in induction therapy is unknown. Between June 01, 2010 and February 28, 2017, 6136 patients at the age of 1 to 17 years with ALL were enrolled onto the trial AIEOP-BFM ALL 2009. The effect of three versus five doses of intrathecal methotrexate during induction therapy on the incidence of severe infectious complications was analyzed. Among 4706 patients treated with three intrathecal methotrexate doses, 77 (1.6%) had a lifethreatening infection during induction as compared to 59 of 1350 (4.4%) patients treated with five doses (p.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30205 - Hematology
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2023
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Haematologica
ISSN
0390-6078
e-ISSN
1592-8721
Svazek periodika
108
Číslo periodika v rámci svazku
12
Stát vydavatele periodika
IT - Italská republika
Počet stran výsledku
9
Strana od-do
3278-3286
Kód UT WoS článku
001163819400003
EID výsledku v databázi Scopus
2-s2.0-85178651465